Page 14 - kpiebook65064

IV โครงการสังเคราะห์ข้อเสนอ
เพื่อเสริมสร้างการอภิบาลระบบยา

medicines, (5) The constraints from budget for operation in Thai-FDA and

remuneration for personnel, (6) The discontinuity of medicinal license reviews
and (7) The lack of technology promotion and medicinal laboratory for

medicinal verification
2. The risk of Drug Selections consists of (1) The appointment and operation

of the National Drug System Development Committee, (2) The role and conflict
between working group on special experts and working group on Health

Economics, (3) The conflict of Interests of the members of committee,
sub-committees and working groups, (4) The relation between pharmaceutical

industries and the National Drug System Development Committee, (5) The lack
of accountable identification to committee and (6) The principles and
regulation for Drug Efficiency and Cost-effectiveness of drug

3. The risk of Public Procurement for medicines consists of (1) The lack of

drug promotion controls (2) The lack of ethical controls to the members of
Pharmacy and Therapeutic Committee (PTC) and health personnel, (3) the

standards and regulations of hospitals, (4) the public procurement regulation,
and (5) the drug cost estimate determinations

The study discovers a various risk in Pharmaceutical Governance in Thailand

therefore the study suggests the policy recommendation for the purpose of
strengthening and improvement for Pharmaceutical Governance in six principles, consists

of (1) the direction of National Drug Policy determination must defines apparently;
(2) the all Acts, Regulations and Policies concerned with Pharmaceutical Governance
must be improved well-timed and consults by participatory with all stakeholders; (3) the

organizations and committees in Pharmaceutical Governance must make clear their roles
and improves a professionalisms in accordance with National Drug Policy; (4) The

information and communications technology (ICT) in Pharmaceutical Governance have to
connects the insignificant and up-to-date information; (5) The professional ethics of all
stakeholders have to promote continuously; and (6) Internal and External Audits must

be developed and strengthened.